Company intelligence / Profile preview

Organon & Co.

Jersey City, New Jersey, United Statesorganon.com ↗

Ownership: Public · OGN
Employees: ~10000
Development stage: Commercial

Overview

Organon has more than sixty commercialized products globally with a strong heritage in women’s health. Its pipeline includes both early-stage assets—such as OG‑6219 for endometriosis now in Phase II—and late-stage/commercial programs. The company has recently expanded through acquisitions and licensing deals for new therapies targeting women’s health needs and biosimilar markets. Clinical results for advanced programs like OG‑6219 are pending completion of ongoing trials expected by late 2024.

Therapeutic areas: Women's HealthEndocrinologyNeurologyImmunology
Modalities: Small moleculesHormones/peptidesMonoclonal antibodies (biosimilars)Devices (contraceptive implants/rings)
Industry: Biotech

Drug pipeline

51 assets

rocuronium

Approved

50 more assets in the full pipeline.

Request access →

Partnerships

Eli Lilly & Company – distribution/promotion of Emgality® and RAYVOW™ for migraine in EuropeSamsung Bioepis – partnership on biosimilars including HADLIMA®/adalimumab-bwwd

Financials

Market cap: $3.6B
Total revenue: $1.6B
Enterprise value: $11B

Beyond the preview

Go deeper on Organon & Co..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Organon & Co..

Explore the full profile